Lanlan Ji

1.4k total citations
54 papers, 693 citations indexed

About

Lanlan Ji is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Lanlan Ji has authored 54 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Rheumatology, 16 papers in Immunology and 9 papers in Genetics. Recurrent topics in Lanlan Ji's work include Systemic Lupus Erythematosus Research (23 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Lanlan Ji is often cited by papers focused on Systemic Lupus Erythematosus Research (23 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Lanlan Ji collaborates with scholars based in China, United States and Australia. Lanlan Ji's co-authors include Zhuoli Zhang, Wenhui Xie, Yan Geng, Xuerong Deng, Hong Huang, Yanjie Hao, Xiaohui Zhang, Dai Gao, Guangtao Li and Xinlei Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

Lanlan Ji

48 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanlan Ji China 19 439 219 101 95 84 54 693
Mary Gayed United Kingdom 9 501 1.1× 419 1.9× 88 0.9× 110 1.2× 45 0.5× 15 849
Lillian Barra Canada 18 658 1.5× 322 1.5× 171 1.7× 92 1.0× 98 1.2× 53 1.2k
Evandro Mendes Klumb Brazil 16 372 0.8× 222 1.0× 35 0.3× 68 0.7× 90 1.1× 53 644
Claudia Alpini Italy 16 524 1.2× 197 0.9× 183 1.8× 58 0.6× 110 1.3× 32 835
Jose Gabriel Erdozain Spain 8 546 1.2× 186 0.8× 68 0.7× 84 0.9× 41 0.5× 12 611
Bertrand Dunogué France 17 375 0.9× 167 0.8× 38 0.4× 80 0.8× 103 1.2× 36 857
Chryssa Papasteriades Greece 17 444 1.0× 378 1.7× 140 1.4× 60 0.6× 157 1.9× 31 918
Luis Alonso González Colombia 16 412 0.9× 248 1.1× 85 0.8× 34 0.4× 35 0.4× 49 547
Íñigo Rúa‐Figueroa Spain 21 682 1.6× 396 1.8× 154 1.5× 197 2.1× 100 1.2× 84 1.1k
Claudio Galarza-Maldonado Mexico 14 396 0.9× 177 0.8× 76 0.8× 50 0.5× 23 0.3× 24 594

Countries citing papers authored by Lanlan Ji

Since Specialization
Citations

This map shows the geographic impact of Lanlan Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Ji more than expected).

Fields of papers citing papers by Lanlan Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Ji. The network helps show where Lanlan Ji may publish in the future.

Co-authorship network of co-authors of Lanlan Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Ji. A scholar is included among the top collaborators of Lanlan Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Ji. Lanlan Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Xiaoying, Yan Geng, Xuerong Deng, et al.. (2025). The concordance of swelling/tenderness with ultrasound-detected inflammatory lesions in patients with psoriatic arthritis. Frontiers in Immunology. 16. 1562996–1562996.
2.
Gao, Dai, Lanlan Ji, Xiaohui Zhang, et al.. (2025). Transitioning from Lupus Low Disease Activity State to remission in systemic lupus erythematosus: real-world evidence. Frontiers in Immunology. 16. 1546306–1546306.
3.
Zhao, Juan, Hong Huang, Yu Wang, et al.. (2024). Real-World Clinical Equivalence of Generic and Branded Tofacitinib: A Prospective Longitudinal Cohort Study in Patients With Rheumatoid Arthritis. Mayo Clinic Proceedings. 99(1). 26–38. 1 indexed citations
4.
Zhang, Xiaohui, Hong Huang, Dai Gao, et al.. (2023). Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study. Rheumatology and Therapy. 10(5). 1199–1213. 4 indexed citations
5.
Geng, Yan, Yong Fan, Xuerong Deng, et al.. (2023). The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic Diseases. Rheumatology and Therapy. 10(4). 1039–1053. 4 indexed citations
6.
8.
Xie, Wenhui, Lanlan Ji, & Zhuoli Zhang. (2022). Sirolimus Monotherapy for Thrombocytopenia in Primary Antiphospholipid Syndrome: A Pilot Study From a Tertiary Referral Center. Frontiers in Immunology. 13. 857424–857424. 9 indexed citations
9.
Hao, Yanjie, Shereen Oon, Lanlan Ji, et al.. (2021). Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohort. Clinical Rheumatology. 41(2). 357–366. 15 indexed citations
10.
Xie, Wenhui, Hong Huang, Guangtao Li, et al.. (2021). Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020. Annals of the Rheumatic Diseases. 80(8). 997–1003. 23 indexed citations
11.
Sun, Xiaoying, Lanlan Ji, Guangtao Li, et al.. (2021). Eyelid erythema as the first manifestation of subcutaneous panniculitis-like T-cell lymphoma mimicking dermatomyositis: a case-based review. Clinical Rheumatology. 41(3). 929–934. 4 indexed citations
12.
Fan, Yong, Yan Geng, Yu Wang, et al.. (2021). Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines. Annals of the Rheumatic Diseases. 81(3). 443–445. 39 indexed citations
14.
Ji, Lanlan, Wenhui Xie, Guangtao Li, & Zhuoli Zhang. (2020). Maintenance to target was associated with radiological outcomes in patients with rheumatoid arthritis: a real-world observational cohort study. Clinical Rheumatology. 40(4). 1307–1315. 2 indexed citations
15.
Xie, Wenhui, Xinlei Yang, Hong Huang, et al.. (2020). Risk of malignancy with non-TNFi biologic or tofacitinib therapy in rheumatoid arthritis: A meta-analysis of observational studies. Seminars in Arthritis and Rheumatism. 50(5). 930–937. 30 indexed citations
16.
Xie, Wenhui, Xinlei Yang, Lanlan Ji, & Zhuoli Zhang. (2020). Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 50(4). 598–607. 20 indexed citations
17.
Ji, Lanlan, Wenhui Xie, & Zhuoli Zhang. (2020). Efficacy and safety of sirolimus in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 50(5). 1073–1080. 38 indexed citations
18.
Song, Yan, Lanlan Ji, & Yingfang Zhou. (2017). Antiphospholipid syndrome and pregnancy. Zhonghua weichan yixue zazhi. 20(6). 458–463. 1 indexed citations
19.
Sun, Xiaoying, Xuerong Deng, Yan Geng, et al.. (2017). A simplified and validated ultrasound scoring system to evaluate synovitis of bilateral wrists and hands in patients with rheumatoid arthritis. Clinical Rheumatology. 37(1). 185–191. 11 indexed citations
20.
Ji, Lanlan, Yan Geng, Yanjie Hao, & Zhuoli Zhang. (2011). Fibroblastic rheumatism: An addition to fibromatosis. Joint Bone Spine. 78(5). 519–521. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026